Table 4 Demographic and clinical features of the patients enrolled in the study and control groups
From: A novel predictive model for phthisis bulbi following facial hyaluronic acid cosmetic injection
Parameters | All enrolled eyes (n = 20) | Study group (n = 10) | Control group (n = 10) | p value |
|---|---|---|---|---|
Demographic | ||||
Sex (male/female) | 1/19 | 1/9 | 0/10 | 1.000 |
Age (years) | 31.95 ± 7.84 | 33.00 ± 8.37 | 30.90 ± 7.58 | 0.564 |
Eye (right/left) | 8/12 | 5/5 | 3/7 | 0.650 |
Clinical features | ||||
Ophthalmoplegia within 24 h | 8(40) | 6(60) | 2(20) | 0.170 |
Ophthalmoplegia at 1-month follow-up | 6(30) | 6(60) | 0(0) | 0.011 |
ASI within 1 month | 12(60) | 10(100) | 2(20) | 0.001 |
ASI at 1-month follow-up | 10(50) | 10(100) | 0(0) | < 0.001 |
NLP at 1-month follow-up | 14(70) | 9(90) | 5 (50) | 0.141 |
Iris atrophy of 360°circumference within 6 months | 4(20) | 4(40) | 0(0) | 0.087 |
Hypotony within 6 months | 8(40) | 8(80) | 0(0) | 0.001 |
NISS Grade 3 | 11(55) | 7(70) | 4(40) | 0.370 |
NISS Grade 3–4 | 14(70) | 9(90) | 5(50) | 0.141 |